Dividend Aristocrats in a Shaky Market: KO, PG, JNJ, and 2 Others Built to Last

Quick Read

  • Colgate-Palmolive (CL) controls 41.3% of toothpaste market. Procter & Gamble (PG) faces $400M tariff headwind. Coca-Cola (KO) posted 5% organic growth. McDonald’s (MCD) delivered 5.7% comparable sales. Johnson & Johnson (JNJ) grew revenue 9.1% to $94.19B and guides ~$100.5B for 2026.

  • Johnson & Johnson ranks first with 9.1% revenue growth and strong pharmaceutical pipeline as market volatility drives investors toward dividend aristocrats with decades-long increase streaks.

  • Read: If you follow markets closely, Kalshi lets you profit directly from being right about what comes next.

By William Temple Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Dividend Aristocrats in a Shaky Market: KO, PG, JNJ, and 2 Others Built to Last

© jittawit21 / Shutterstock.com

The market’s fear gauge tells the story clearly. The VIX hit 21.15 as of March 4, 2026, up 29.4% in a single month. Consumer sentiment sits at 56.4 on the University of Michigan index, deep in pessimistic territory. The 10-year Treasury still sits at 4.09%, keeping investors on edge.

When the ground shakes, investors reach for companies that have been paying and raising dividends longer than most people have been investing. These five Dividend Aristocrats have earned that reputation quarter after quarter, decade after decade. Here is how they stack up, ranked from good to great.

#5: Colgate-Palmolive (CL)

Colgate-Palmolive (NYSE:CL) has been raising its dividend for 62 consecutive years, and its $0.52 quarterly dividend keeps that streak alive. But Q4 2025 results were hard to love. Revenue came in at $5.23B, missing estimates of $5.27B, and a GAAP loss driven by goodwill impairment charges on its skin health business left a mark. The base business held at $0.95 adjusted EPS, but full-year organic sales guidance was trimmed to 1%-4% for 2026. Colgate controls 41.3% of the global toothpaste market, a genuine moat. But slowing category growth and impairment charges make this the weakest entry on the list.

#4: Procter & Gamble (PG)

Procter & Gamble (NYSE:PG) has been raising its dividend for over 65 consecutive years, the longest streak on this list. The $1.0568 quarterly dividend was declared again this week. But Q2 FY2026 results showed strain. Revenue of $22.21B missed estimates, organic sales were flat, and the company faces a $400M after-tax tariff headwind. Unit volume slipped 1%. New CEO Shailesh Jejurikar has a real challenge ahead. FY2026 guidance of core EPS of $6.83-$7.09 is fine but uninspiring. P&G is stability personified, but it is fighting margin compression on multiple fronts.

#3: Coca-Cola (KO)

Coca-Cola (NYSE:KO) just raised its quarterly dividend to $0.53, marking 63 consecutive years of dividend increases. Q4 2025 showed 5% organic revenue growth, and Coca-Cola Zero Sugar volumes surged 13% in the quarter. The company paid out $8.8B in dividends in 2025 and guided for 7%-8% comparable EPS growth in 2026. The $960M BODYARMOR impairment and a revenue miss keep it from ranking higher, but with a beta of just 0.332 and a loyal global consumer base, Coke has the kind of low-beta, consistent dividend profile that has historically attracted income-focused investors.

#2: McDonald’s (MCD)

McDonald’s (NYSE:MCD) delivered one of the most impressive comp sales recoveries in its recent history. Global comparable sales hit +5.7% in Q4 2025, compared to just +0.4% a year earlier. U.S. comps swung from -1.4% to +6.8% in one year. CEO Chris Kempczinski captured it well:

“McDonald’s value leadership is working. By listening to customers and taking action, we have improved traffic and strengthened our value & affordability scores.”

The loyalty program now drives nearly $37B in annual systemwide sales with 210 million 90-day active users. The dividend has been raised for 49 consecutive years. Negative shareholders equity and ongoing restructuring are real risks, but the operational momentum is hard to ignore.

#1: Johnson & Johnson (JNJ)

Johnson & Johnson (NYSE:JNJ) ranks first on this list by the metrics examined here. Revenue grew 9.1% year over year in Q4 2025, with full-year revenue hitting $94.19B. DARZALEX grew 26.6% and TREMFYA exploded 67.6%. The 2026 guidance calls for revenue of ~$100.5B with adjusted EPS of $11.53. The dividend has been raised for 63 consecutive years, with the most recent quarterly payment of $1.30 per share. J&J carries one of only two AAA credit ratings among U.S. companies, and its planned separation of the DePuy Synthes orthopedics business could be a significant corporate development for the company. With a beta of just 0.326 and a pipeline firing on multiple cylinders, J&J combines low beta with strong revenue growth and a 63-year dividend increase streak.

The Bottom Line

When the VIX spikes and consumer confidence sinks, these five companies have continued raising their dividends through recessions, financial crises, and global pandemics. Their dividend growth streaks span decades of volatile markets. Johnson & Johnson posted the strongest revenue growth and pipeline metrics among the five companies reviewed, but every name on this list has a long track record of dividend growth through volatile markets. The dividends keep coming whether the market cooperates or not.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CF Vol: 8,217,044
+$5.00
+4.51%
$115.78
BA Vol: 10,634,914
+$9.05
+4.08%
$231.11
KR Vol: 10,635,022
+$2.54
+3.55%
$74.11
NOW Vol: 25,903,908
+$3.96
+3.29%
$124.34
BR Vol: 1,687,546
+$5.99
+3.14%
$196.88

Top Losing Stocks

TER Vol: 5,878,230
-$32.53
10.65%
$273.05
GLW Vol: 19,045,570
-$11.45
8.50%
$123.29
ODFL Vol: 3,333,363
-$16.71
7.93%
$193.97
BLK Vol: 1,841,626
-$79.55
7.69%
$955.45
LRCX Vol: 13,376,916
-$15.35
7.15%
$199.33